An Elderly Patient with Abdominal Pain: Hypereosinophilic Syndrome

Main Article Content

Chong Sook Vui
Kua Chin Hong
Nan Nitra Than


Hypereosinophilic Syndrome (HES) is diagnosed when there is peripheral hypereosinophilia with eosinophil count of more than >1500/µL. The duration of the illness usually lasts more than 6 months, with evidence of target organ damage, affecting mainly the skin, heart, and neurological system, without apparent aetiology. This case report details a case of hypereosinophilic syndrome in an 80-year-old man with multiple co-morbidities, who presented with unexplained peripheral eosinophilia, intermittent skin rashes, cardiac, respiratory, and abdominal symptoms. It is important to consider the diagnosis of hypereosinophilic syndrome when there is an unexplained peripheral eosinophilia, and thus intervene rapidly to prevent life-threatening complications.

Peripheral eosinophilia, skin rash, cardiac symptoms, respiratory symptoms, abdominal symptoms, hypereosinophilic syndrome.

Article Details

How to Cite
Vui, C. S., Hong, K. C., & Than, N. N. (2019). An Elderly Patient with Abdominal Pain: Hypereosinophilic Syndrome. Asian Journal of Case Reports in Medicine and Health, 2(3), 1-8. Retrieved from
Case Report


Gotlib J. World Health Organization-defined eosinophilic disorders: Update on diagnosis, risk stratification, and management. Am J Hematol. 2017;92: 1243–1259.

Curtis C, Ogbogu P. Hypereosinophilic syndrome. Clin Rev Allergy Immunol. 2016;50(2):240-51.

Roufosse FE, Goldman M, Cogan E. Hypereosinophilic syndromes. Orphanet J Rare Dis. 2007;2:37.

European Medicines Agency, Committee for Orphan Medicinal Products. Public summary of opinion on orphan designation: Mepolizumab for the treatment of hypereosinophilc syndrome; 2010.

Wardlaw AJ, Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, et al. Eosinophils and related disorders. Williams Hematology. 9th Ed. New York, NY: McGraw-Hill Education. 2016;947-64.

Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975; 54(1):1-27.

Lefebvre C, Bletry O, Degoulet P, et al. Prognostic factors of hypereosinophilic syndrome. Study of 40 cases. Ann Med Interne (Paris). 1989;140(4):253-7. [French]

Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med. 1968;68:1220-1229.

Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroentero Clin North Am. 2014;43(2): 317-327.

Bosslet GT, Noor A. Severe idiopathic hypereosinophilic syndrome. Respiratory Medicine CME. 2008;1(2):100-102.

Karnak D, Kayacan O, Beder S, Delibalta M. Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma. CMAJ. 2003;168(2): 172-175.

May LP, Kelly J, Sanchez M. Hypereosinophilic syndrome with unusual cutaneous manifestations in two men with HIV infection. J Amer Acad Derm. 1990;23: 202-4.

Schwartz LB, Sheikh J, Singh A. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab. Curr Med Res Opin. 2010;26(8):1933-46.

Strati P, Cortes J, Faderl S, Kantarjian H, Verstovsek S. Long term follow-up of patients with hypereosinophilic syndrome treated with Alemtuzumab, an anto-CD52 antibody. Clin Lymphoma Myeloma Leuk. 2013;13(3):287-91.

Sempau L, Leticia M, Luna PC, Casas J, Staiger H. Eosinophilic annular erythema. Dermatology Online Journal. 2012;18(3): 8.